MOLINA HEALTHCARE, INC. MOH
MOLINA HEALTHCARE, INC. (MOH) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $45.4B at a 1.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-28 | Wells Fargo | Equal-Weight (main) |
| 2026-07-24 | Truist Securities | Hold (main) |
| 2026-07-24 | RBC Capital | Sector Perform (main) |
| 2026-07-24 | Barclays | Underweight (main) |
| 2026-07-14 | TD Cowen | Hold (main) |
| 2026-07-14 | Truist Securities | Hold (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Finance, Insurance & Real Estate · percentile among 1152 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.326 |
| Retained earnings / assets | 0.231 |
| EBIT / assets | 0.05 |
| Equity / liabilities | 0.354 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MOH | MOLINA HEALTHCARE, INC. | 4/9 | 3.6 | 25.4 | +11.7% |
| OSCR | Oscar Health, Inc. | 4/9 | -2.18 | — | +27.5% |
| ALHC | Alignment Healthcare, Inc. | 5/9 | -0.35 | — | +46.1% |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | 2/9 | -12.26 | — | +40.3% |
| TRUP | TRUPANION, INC. | 2/9 | 2.14 | — | +11.9% |
| HUM | HUMANA INC | 5/9 | 5.1 | 38.8 | +10.1% |
| CNC | CENTENE CORP | 4/9 | 0.38 | — | +19.4% |
All Finance, Insurance & Real Estate companies →
About MOLINA HEALTHCARE, INC.
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
FAQ
Is MOH financially healthy?
MOLINA HEALTHCARE, INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MOH pay a dividend?
No, MOLINA HEALTHCARE, INC. does not currently pay a dividend.
How profitable is MOH?
In FY2025, MOLINA HEALTHCARE, INC. had a net margin of 1.0% and a return on equity of 11.6%.
Is MOH overvalued or undervalued?
MOLINA HEALTHCARE, INC. trades at about 21.4× trailing earnings — near its 10-year norm (10-year range 10.7×–61.7×, median 20.1×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MOH?
The average Wall-Street price target for MOLINA HEALTHCARE, INC. is $209.12, about 9.6% above the recent price, from 17 analysts (consensus: hold).
Is MOH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MOLINA HEALTHCARE, INC.: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 25.4×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.